Integrin αvβ6 is up-regulated in ovarian cancer [21] and is a driver of EMT, which activates TGF-β1 through binding to the RGD motif contained within LAP, which is linked to inactive TGF-β1 [47]. Here, TGFB2 is linked to ovarian carcinoma.